FMO5 and Stroke: Additionally, targeting CD39,[71] the NETs-vWF axis,[55,72] PAD4, and NADPH oxidase,[36] inhibiting CD147,[73] and suppressing plasma kallikrein all have inhibitory effects on the formation of stroke.[74]